After the overwhelming success of 1st Biotechnology World Congress" the organizers feel immense pleasure to announce the "2nd Biotechnology World Congress" (2nd BWC) to be held in Dubai, UAE, from February 18th-21st, 2013. Keeping in consideration the long list of prospective participants who could not be accommodated in the 1st Biotechnology World Congress due to its limited duration of just two days, 2nd BWC will now be a four day international conference featuring lectures and poster presentations on selected topics by leaders in the field from academia and industry. The 2nd BWC will be unique in promoting the translational nature of modern biotechnological research, with emphasis on both the basic science in industry and academia as well as its practical and clinical applications. Presentations would focus on pharmaceutical biotechnology, vaccines, CNS, cancer, antibodies, protein engineering, plant and environmental technologies, transgenic plant and crops, bioremediation, microbial diversity research, business development, strategic alliances, partnering trends, product opportunities, growth business models and strategies, licensing etc.The principal goal of this symposium will be to present the world with the breakthroughs in Biotechnology and bring together both young and experienced scientists from all regions of the world to open up avenues for their meaningful collaboration at regional and global level. The best current research and non-commercial aspects of the field will be reviewed.A number of Nobel Laureates will deliver keynote lectures at the conference. There will be sessions in all the major areas of biotechnology, classed on the basis of areas as given below.An International Advisory Board has been convened consisting of eminent scientists from all over the world, including among its members, four Nobel laureates. Please visit the web site http://dubaiconf02.com/bwc for details.The details of the conference can be viewed at http://dubaiconf02.com/bwcThis is an incredible opportunity to showcase your basic research, findings and practices in the various thematic sessions stated below.The conference offers the following sessions in biotechnology:1. Pharmaceutical Biotechnology: biopharmaceuticals discovery (CNS, cancer, cardiovascular, endocrine, immune); vaccines; antibodies; protein engineering.2. Plant and Environment: transgenic plants and crops; bioremediation; microbial diversity; bio-monitoring; photosynthetic microorganisms, cyanobacteria and microalgae.3. Industrial and Manufacturing: bio-fuels; energy crops (cellulosic ethanol industry); industrial enzymes; bioprocess engineering and optimization.4. Medical Biotechnology: biopharmaceutical manufacturing; diagnostics; imaging; pharmacogenomics (personalized medicine); microarray technology; biomarkers.5. Business development: strategic alliances; partnering trends; product opportunities; growth; business models and strategies; licensing; merger and acquisitions; outsourcing; venture capital and financing; intellectual property. 6. Regenerative Medicine: stem cells, gene therapy; tissue engineering; cell based therapy; cell cultivation.7. Other areas: Food; Marine; Bio-safety; Systems Biology, Clinical Research/clinical trials; bioethics; nanobiotechnology.Abstracts for consideration as Invited or Session Lectures, and Poster Presentations can be submitted at http://dubaiconf02.com/bwc Alternatively, a maximum one-page length abstract written in English can be submitted to us by e-mail at info@dubaiconf03.com All submitted abstracts received will be reviewed on the basis of scientific merit, novelty and practical application. Due to the limited slots available, only the best abstracts will be selected. The abstracts of the conference and a selection of the proceedings will be published in a high Impact Factor journal by an international publisher. We suggest that all interested